School of Medical Imaging, Tianjin Medical University, Tianjin 300203, China.
Department of Ultrasound, Tianjin Medical University General Hospital, Tianjin 300052, China.
ACS Biomater Sci Eng. 2020 Jul 13;6(7):4276-4284. doi: 10.1021/acsbiomaterials.9b01933. Epub 2020 Jun 29.
Photothermal agents with good biocompatibility, high tumor accumulation efficiency, large-scale production ability, and low cost are crucial for potential photothermal treatment in clinic. Herein, we proposed a green and highly efficient strategy to fabricate a kilogram-scale alginate-Ca-Fe powder hydrogel (ALG-Ca-Fe) by turning commercial Fe powder into hydrogel for enhanced photothermal therapy. The ALG-Ca-Fe was formed by simply dispersing commercial Fe powder into the preformed alginate-Ca hydrogel in a green and energy-/time-saving way. The hydrogel exhibited the advantages of ultrahigh loading capacity of Fe powder (>100 mg mL), excellent large-scale production capacity (>1 kg in lab synthesis), low cost (<1.7 $/kg), and good injectability. More importantly, large size and hydrophobicity endowed Fe powder with excellent tumor retention effect and minimal diffusion to surrounding tissues, greatly benefiting improving treatment efficiency and reducing side effects. In vivo and in vitro studies both proved that the large-scale produced ALG-Ca-Fe can be used for highly efficient and biosafe tumor treatment in vivo by simple noninvasive injection. The developed ALG-Ca-Fe with multiple superiors opens up a novel green way to develop efficient and safe photothermal therapeutic agents with great clinic transformation potential.
具有良好生物相容性、高肿瘤积累效率、大规模生产能力和低成本的光热试剂对于临床潜在的光热治疗至关重要。在此,我们提出了一种绿色高效的策略,通过将商业铁粉转化为水凝胶来制备公斤级海藻酸钠-Ca-Fe 粉末水凝胶(ALG-Ca-Fe),以增强光热治疗效果。ALG-Ca-Fe 通过简单地将商业铁粉分散到预先形成的海藻酸钠-Ca 水凝胶中,以绿色、节能/省时的方式形成。该水凝胶具有超高的铁粉负载能力(>100mg/mL)、出色的大规模生产能力(实验室合成>1kg)、低成本(<1.7 美元/千克)和良好的可注射性等优点。更重要的是,大尺寸和疏水性赋予了铁粉优异的肿瘤保留效果和最小的向周围组织扩散,极大地有利于提高治疗效率和降低副作用。体内和体外研究均证明,通过简单的非侵入性注射,大规模生产的 ALG-Ca-Fe 可用于体内高效且生物安全的肿瘤治疗。具有多种优势的 ALG-Ca-Fe 为开发高效、安全的光热治疗剂开辟了一条新的绿色途径,具有巨大的临床转化潜力。